Science as the Foundation

Innovation as the Forefront

FindCure Biosciences (ZhongShan) Co., Ltd was founded in 2019 and led by renowned biopharmaceutical industry experts and clinical oncologists, the Company is a high-tech innovative biopharmaceutical enterprise driven by exceptional in-house R&D capabilities. With comprehensive expertise in preclinical research, translational medicine, and clinical development, the Company has established three proprietary platforms: targeted drug discovery, radionuclide drug conjugate (RDC), and boron neutron capture therapy (BNCT). The Company's pipeline focuses on lung cancer, gastric cancer, urological cancers, and other areas with significant unmet medical needs, with the goal of developing breakthrough First-in-Class or Best-in-Class drugs for the global market.

The Company has built over 1,000 square meters of laboratory space, encompassing medicinal chemistry laboratories, pharmacology and pharmacodynamics laboratories, pharmaceutical analysis laboratories, and pharmaceutical formulation laboratories.